SS Innovations International (SSII) Other Accumulated Expenses (2017 - 2026)
SS Innovations International (SSII) reported Other Accumulated Expenses of $6.3 million for Q1 2026, up 341.41% on a YoY basis from $1.4 million in Q1 2025, and up 8.6% sequentially from $5.8 million in Q4 2025.
SS Innovations International (SSII) Other Accumulated Expenses (2017 - 2026) Analysis & Trends
SS Innovations International (SSII) has 8 years of Other Accumulated Expenses data on file, last reported at $6.3 million in Q1 2026.
- For the quarter ending Q1 2026, Other Accumulated Expenses rose 341.41% year-over-year to $6.3 million; the trailing twelve-month figure through Mar 2026 stood at $6.3 million (up 341.41% YoY), and the FY2025 full-year result was $5.8 million, up 209.09% from the prior year.
- Other Accumulated Expenses climbed to $6.3 million in Q1 2026, from $5.8 million in the prior quarter.
- In the past five years, Other Accumulated Expenses ranged from a high of $6.3 million in Q1 2026 to a low of $489939.0 in Q4 2023.
- A 5-year average of $2.2 million and a median of $1.4 million in 2024 frame the typical range for Other Accumulated Expenses.
- Across the five-year window, Other Accumulated Expenses slipped 1.64% in 2023 and soared 341.41% in 2026, its largest moves.
- Tracing SSII's Other Accumulated Expenses over 5 years: stood at $498097.0 in 2022, then retreated by 1.64% to $489939.0 in 2023, then soared by 284.7% to $1.9 million in 2024, then soared by 209.09% to $5.8 million in 2025, then climbed by 8.6% to $6.3 million in 2026.
- Business Quant data shows SSII's Other Accumulated Expenses at $6.3 million in Q1 2026, $5.8 million in Q4 2025, and $3.6 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 182.61 Bn | 175.32 Bn | 6.27 Bn |
| 2 | Stryker | 128.95 Bn | 126.07 Bn | 3.81 Bn |
| 3 | Medtronic | 108.22 Bn | 99.00 Bn | 6.41 Bn |
| 4 | Boston Scientific | 68.29 Bn | 66.84 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 48.30 Bn | 44.63 Bn | 1.29 Bn |
| 6 | Dexcom | 28.31 Bn | 27.19 Bn | 750.30 Mn |
| 7 | GE HealthCare Technologies | 28.03 Bn | 25.75 Bn | 1.98 Bn |
| 8 | Smith & Nephew | 27.01 Bn | 26.43 Bn | - |
| 9 | Koninklijke Philips | 24.04 Bn | 20.91 Bn | 2.07 Bn |
| 10 | SS Innovations International | 754.63 Mn | 731.02 Mn | 5.33 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 6.33 Mn |
| Dec 31, 2025 | 5.83 Mn |
| Sep 30, 2025 | 3.61 Mn |
| Mar 31, 2025 | 1.43 Mn |
| Dec 31, 2024 | 1.88 Mn |
| Sep 30, 2024 | 1.91 Mn |
| Jun 30, 2024 | 1.18 Mn |
| Mar 31, 2024 | 1.36 Mn |
| Dec 31, 2023 | 489,939.00 |
| Sep 30, 2023 | 696,580.00 |
| Jun 30, 2023 | 820,510.00 |
| Dec 31, 2022 | 498,097.00 |
| Sep 30, 2019 | 70,241.00 |
| Jun 30, 2019 | 96,591.00 |
| Mar 31, 2019 | 71,492.00 |
| Dec 31, 2018 | 81,313.00 |
| Sep 30, 2018 | 202,125.00 |
| Jun 30, 2018 | 84,000.00 |
| Mar 31, 2018 | 62,250.00 |
| Dec 31, 2017 | 284,750.00 |